Clinical Trial Update: Rheopheresis Blood Filtration Study for the Treatment of Dry Age-Related Macular Degeneration (AMD) [Phase 3]

View source ↗

Summary

Clinical trial update on a Phase 3 rheopheresis blood filtration study for dry age-related macular degeneration; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Rheopheresis Blood Filtration

Snippet

Sponsor: OccuLogix | Conditions: Macular Degeneration | Phase 3 | Status: UNKNOWN